1. Home
  2. MDAI

as of 01-22-2026 10:49am EST

$1.61
+$0.06
+4.22%
Stocks Health Care Medical/Dental Instruments Nasdaq

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

Founded: 2013 Country:
United States
United States
Employees: N/A City: DALLAS
Market Cap: 48.8M IPO Year: N/A
Target Price: $3.25 AVG Volume (30 days): 300.0K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.69 EPS Growth: N/A
52 Week Low/High: $1.04 - $3.21 Next Earning Date: 11-11-2025
Revenue: $23,168,000 Revenue Growth: -15.02%
Revenue Growth (this year): -36.27% Revenue Growth (next year): -23.91%

Latest Spectral AI Inc. News

MDAI Breaking Stock News: Dive into MDAI Ticker-Specific Updates for Smart Investing

All MDAI News

Share on Social Networks: